ARMISTICE CAPITAL, LLC - Q2 2020 holdings

$2.28 Billion is the total value of ARMISTICE CAPITAL, LLC's 79 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 48.1% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$200,434,000
+29.6%
6,500
+8.3%
8.79%
-8.1%
IWM BuyISHARES TRput$171,816,000
+114.4%
12,000
+71.4%
7.54%
+52.1%
CERC BuyCERECOR INC$77,777,000
+11.4%
29,914,285
+6.2%
3.41%
-21.0%
UNH BuyUNITEDHEALTH GROUP INC$58,990,000
+168.8%
200,000
+127.3%
2.59%
+90.6%
BMY BuyBRISTOL-MYERS SQUIBB CO$58,800,000
+62.8%
1,000,000
+54.3%
2.58%
+15.4%
BIIB BuyBIOGEN INC$57,791,000
+214.9%
216,000
+272.4%
2.54%
+123.3%
ALXN BuyALEXION PHARMACEUTICALS INC$56,120,000
+46.0%
500,000
+16.8%
2.46%
+3.6%
VNDA BuyVANDA PHARMACEUTICALS INC$54,912,000
+16.0%
4,800,000
+5.1%
2.41%
-17.7%
ENR BuyENERGIZER HLDGS INC NEW$54,519,000
+106.7%
1,148,000
+31.7%
2.39%
+46.6%
MDT NewMEDTRONIC PLC$54,286,000592,000
+100.0%
2.38%
SUPN SellSUPERNUS PHARMACEUTICALS INC$52,440,000
-2.8%
2,208,000
-26.4%
2.30%
-31.1%
LNTH BuyLANTHEUS HLDGS INC$51,823,000
+206.8%
3,624,000
+173.7%
2.27%
+117.5%
INCY SellINCYTE CORP$45,331,000
+17.2%
436,000
-17.4%
1.99%
-16.9%
CENTA SellCENTRAL GARDEN & PET COcl a non-vtg$44,738,000
+16.6%
1,324,000
-11.7%
1.96%
-17.3%
REGN BuyREGENERON PHARMACEUTICALS$42,408,000
+35.7%
68,000
+6.2%
1.86%
-3.7%
FIVE BuyFIVE BELOW INC$40,413,000
+71.6%
378,005
+13.0%
1.77%
+21.8%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$36,555,000
+1.7%
500,000
-52.7%
1.60%
-27.9%
DBX SellDROPBOX INCcl a$35,354,000
+15.4%
1,624,000
-4.0%
1.55%
-18.1%
DG BuyDOLLAR GEN CORP NEW$35,325,000
+41.2%
185,421
+11.9%
1.55%
+0.1%
ROST BuyROSS STORES INC$34,892,000
+240.8%
409,344
+247.7%
1.53%
+141.7%
BLUE SellBLUEBIRD BIO INC$34,671,000
+16.4%
568,000
-12.3%
1.52%
-17.4%
AMZN SellAMAZON COM INC$34,485,000
-23.1%
12,500
-45.7%
1.51%
-45.4%
ATR BuyAPTARGROUP INC$32,250,000
+116.0%
288,000
+92.0%
1.42%
+53.3%
AZO NewAUTOZONE INC$31,587,00028,000
+100.0%
1.38%
AMAG  AMAG PHARMACEUTICALS INC$31,518,000
+23.8%
4,120,0000.0%1.38%
-12.2%
MRTX SellMIRATI THERAPEUTICS INC$31,054,000
+29.5%
272,000
-12.8%
1.36%
-8.2%
BBY NewBEST BUY INC$28,967,000331,919
+100.0%
1.27%
CPRX BuyCATALYST PHARMACEUTICALS INC$28,644,000
+37.8%
6,200,000
+14.8%
1.26%
-2.3%
BURL SellBURLINGTON STORES INC$28,627,000
-30.0%
145,364
-43.7%
1.26%
-50.3%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$28,086,000
+94.8%
248,000
+14.8%
1.23%
+38.1%
ZYME NewZYMEWORKS INC$28,062,000778,000
+100.0%
1.23%
MRK BuyMERCK & CO. INC$27,839,000
+20.6%
360,000
+20.0%
1.22%
-14.4%
TWNK BuyHOSTESS BRANDS INCcl a$27,837,000
+161.1%
2,278,000
+127.8%
1.22%
+85.3%
CL BuyCOLGATE PALMOLIVE CO$26,960,000
+125.7%
368,000
+104.4%
1.18%
+59.9%
FTDR SellFRONTDOOR INC$26,243,000
+17.9%
592,000
-7.5%
1.15%
-16.4%
VYGR SellVOYAGER THERAPEUTICS INC$26,224,000
+28.2%
2,078,000
-7.1%
1.15%
-9.1%
KHC SellKRAFT HEINZ CO$25,512,000
-14.1%
800,000
-33.3%
1.12%
-39.1%
PTCT SellPTC THERAPEUTICS INC$25,370,000
-5.2%
500,000
-16.7%
1.11%
-32.7%
CMG BuyCHIPOTLE MEXICAN GRILL INC$25,257,000
+129.8%
24,000
+42.9%
1.11%
+62.9%
FL NewFOOT LOCKER INC$23,758,000814,740
+100.0%
1.04%
BCOR NewBLUCORA INC$23,388,0002,048,000
+100.0%
1.03%
UBER BuyUBER TECHNOLOGIES INC$22,875,000
+201.2%
736,000
+170.6%
1.00%
+113.4%
AVYA BuyAVAYA HLDGS CORP$22,693,000
+76.2%
1,836,000
+15.3%
1.00%
+25.0%
MDLZ BuyMONDELEZ INTL INCcl a$21,884,000
+45.7%
428,000
+42.7%
0.96%
+3.3%
KFY BuyKORN FERRY$21,880,000
+499.8%
712,000
+374.7%
0.96%
+324.8%
EPC SellEDGEWELL PERS CARE CO$21,812,000
+13.2%
700,000
-12.5%
0.96%
-19.6%
CPB SellCAMPBELL SOUP CO$21,639,000
-1.9%
436,000
-8.8%
0.95%
-30.4%
SMAR BuySMARTSHEET INC$21,183,000
+372.5%
416,000
+285.2%
0.93%
+235.4%
LOW BuyLOWES COS INC$18,297,000
+94.6%
135,416
+24.0%
0.80%
+38.2%
ENTA SellENANTA PHARMACEUTICALS INC$16,268,000
-44.3%
324,000
-43.0%
0.71%
-60.5%
DPZ BuyDOMINOS PIZZA INC$15,625,000
+98.1%
42,295
+73.8%
0.68%
+40.4%
ORLY NewOREILLY AUTOMOTIVE INC$15,448,00036,635
+100.0%
0.68%
AIMT BuyAIMMUNE THERAPEUTICS INC$15,440,000
+78.5%
924,000
+54.0%
0.68%
+26.5%
ARGX NewARGENX SEsponsored adr$15,316,00068,000
+100.0%
0.67%
KSS NewKOHLS CORP$15,272,000735,302
+100.0%
0.67%
ASMB SellASSEMBLY BIOSCIENCES INC$13,899,000
+29.4%
596,000
-17.7%
0.61%
-8.1%
CRSP SellCRISPR THERAPEUTICS AGnamen akt$13,816,000
+38.0%
188,000
-20.3%
0.61%
-2.1%
EGRX NewEAGLE PHARMACEUTICALS INC$13,530,000282,000
+100.0%
0.59%
CVS SellCVS HEALTH CORP$11,175,000
-50.2%
172,000
-54.5%
0.49%
-64.7%
CLVS NewCLOVIS ONCOLOGY INC$10,800,0001,600,000
+100.0%
0.47%
MNKKQ SellMALLINCKRODT PUB LTD COcall$10,720,000
+4.1%
40,000
-23.1%
0.47%
-26.2%
JACK NewJACK IN THE BOX INC$10,054,000135,703
+100.0%
0.44%
ESTC NewELASTIC N V$9,221,000100,000
+100.0%
0.40%
ZEN BuyZENDESK INC$8,853,000
+138.4%
100,000
+72.4%
0.39%
+68.7%
EYEG  EYEGATE PHARMACEUTICALS INC$8,733,000
-7.5%
1,815,5000.0%0.38%
-34.4%
TMO SellTHERMO FISHER SCIENTIFIC INC$8,696,000
+9.5%
24,000
-14.3%
0.38%
-22.4%
ADMS  ADAMAS PHARMACEUTICALS INC$7,020,000
-11.4%
2,742,0000.0%0.31%
-37.1%
BKNG NewBOOKING HOLDINGS INC$6,369,0004,000
+100.0%
0.28%
TTPH  TETRAPHASE PHARMACEUTICALS I$3,577,000
+96.9%
1,419,5070.0%0.16%
+40.2%
ONCT NewONCTERNAL THERAPEUTICS INC$3,569,0001,256,717
+100.0%
0.16%
CRI SellCARTERS INC$3,406,000
-75.9%
42,201
-80.4%
0.15%
-83.0%
TMDI NewTITAN MED INC$1,973,0002,363,457
+100.0%
0.09%
ITRM NewITERUM THERAPEUTICS PLC$1,502,0001,262,553
+100.0%
0.07%
VXRT SellVAXART INC$1,288,000
-97.1%
145,523
-99.4%
0.06%
-98.0%
YTRA NewYATRA ONLINE INC$1,223,0001,800,000
+100.0%
0.05%
NERV  MINERVA NEUROSCIENCES INC$1,083,000
-40.0%
300,0000.0%0.05%
-57.1%
MDGS  MEDIGUS LTDsponsored ads$962,000
+343.3%
1,285,7150.0%0.04%
+223.1%
RIGL NewRIGEL PHARMACEUTICALS INC$957,000522,700
+100.0%
0.04%
BuyPREDICTIVE ONCOLOGY INC$795,000
+93.9%
484,624
+86.4%
0.04%
+40.0%
ExitTENAX THERAPEUTICS INC$0-181,153
-100.0%
-0.01%
CAPR ExitCAPRICOR THERAPEUTICS INC$0-268,630
-100.0%
-0.02%
HSDT ExitHELIUS MED TECHNOLOGIES INC$0-1,840,567
-100.0%
-0.04%
OTLK ExitOUTLOOK THERAPEUTICS INC$0-1,412,382
-100.0%
-0.05%
NNBR ExitNN INC$0-500,000
-100.0%
-0.05%
PGNX ExitPROGENICS PHARMACEUTICALS IN$0-350,000
-100.0%
-0.08%
NTGN ExitNEON THERAPEUTICS INC$0-1,050,000
-100.0%
-0.17%
LB ExitL BRANDS INC$0-262,114
-100.0%
-0.19%
ADUS ExitADDUS HOMECARE CORP$0-52,000
-100.0%
-0.22%
BWXT ExitBWX TECHNOLOGIES INC$0-100,000
-100.0%
-0.30%
TGTX ExitTG THERAPEUTICS INC$0-768,000
-100.0%
-0.47%
ATVI ExitACTIVISION BLIZZARD INC$0-136,000
-100.0%
-0.50%
KMB ExitKIMBERLY CLARK CORP$0-88,000
-100.0%
-0.70%
EPC ExitEDGEWELL PERS CARE COcall$0-5,000
-100.0%
-0.74%
V ExitVISA INC$0-87,000
-100.0%
-0.87%
TGT ExitTARGET CORP$0-180,000
-100.0%
-1.04%
PFE ExitPFIZER INC$0-678,000
-100.0%
-1.37%
DLTR ExitDOLLAR TREE INC$0-305,183
-100.0%
-1.39%
DECK ExitDECKERS OUTDOOR CORP$0-227,518
-100.0%
-1.88%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings